Erratum: Correspondence of fatty acid and drug binding sites on human serum albumin: A two-dimensional nuclear magnetic resonance study (Biochemistry (2013) 52:9 (1559-1567) DOI:10.1021/bi301458b);Correspondence of fatty acid and drug binding sites on human serum albumin: A two-dimensional nuclear magnetic resonance study

Biochemistry

Volumn 52, Issue 9, 2013, Pages 1559-1567

  Krenzel, Eileen S ^a   Chen, Zhongjing ^a   Hamilton, James A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLEIC ACID; SPECTRUM ANALYSIS; TWO DIMENSIONAL;

2-D NMR; DRUG BINDING SITES; HIGH-AFFINITY SITES; HUMAN SERUM ALBUMINS; LIGAND BINDING; MOLAR RATIO; MUTUAL EFFECTS; NMR PEAKS; NUCLEAR MAGNETIC RESONANCE(NMR); REVERSE ORDER; SENSITIVE PROBE; SITE-SPECIFIC; TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE;

BINDING SITES;

FATTY ACID; HUMAN SERUM ALBUMIN; METHYL BETA CYCLODEXTRIN; OLEIC ACID;

ARTICLE; DRUG BINDING SITE; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

EID: 84874625942     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi400314u     Document Type: Erratum

References (48)

1. Peters, T. (1996) All About Albumin. Biochemistry, Genetics, and Medical Applications, Academic Press, San Diego.
2. He, X. M. and Carter, D. C. (1992) Atomic structure and chemistry of human serum albumin Nature 358, 209-215
3. Curry, S., Mandelkow, H., Brick, P., and Franks, N. (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nat. Struct. Biol. 5, 827-835 (Pubitemid 28402087)
4. Sudlow, G., Birkett, D. J., and Wade, D. (1975) The characterization of two specific drug binding sites on human serum albumin Mol. Pharmacol. 11, 824-832
5. Sudlow, G., Birkett, D. J., and Wade, D. N. (1976) Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12, 1052-1061
6. Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., and Curry, S. (2005) Structural basis of the drug-binding specificity of human serum albumin J. Mol. Biol. 353, 38-52 (Pubitemid 41338838)
7. Schmidt, S., Gonzalez, D., and Derendorf, H. (2010) Significance of protein binding in pharmacokinetics and pharmacodynamics J. Pharm. Sci. 99, 1107-1122
8. Benet, L. Z. and Hoener, B.-A. A. (2002) Changes in plasma protein binding have little clinical relevance Clin. Pharmacol. Ther. 71, 115-121 (Pubitemid 34271114)
9. Brunton, L., Lazo, J., and Parker, K., Eds. (2006) Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 11th ed., McGraw-Hill, New York.
10. Maisels, M. J., Baltz, R. D., Bhutani, V. K., Newman, T. B., Rosenfeld, W., Stevenson, D. K., Weinblatt, H. B., Homer, C. J., and Herrerias, C. (2001) Neonatal jaundice and kernicterus Pediatrics 108, 763-765 (Pubitemid 32786610)
11. Ostrow, J. D., Pascolo, L., Shapiro, S. M., and Tiribelli, C. (2003) New concepts in bilirubin encephalopathy Eur. J. Clin. Invest. 33, 988-997 (Pubitemid 37421598)
12. Shapiro, S. M. (2003) Bilirubin toxicity in the developing nervous system Pediatric Neurology 29, 410-421 (Pubitemid 37543676)
13. 13C nuclear magnetic resonance study J. Clin. Invest. 87, 1431-1441
14. Brodersen, R., Andersen, S., Vorum, H., Nielsen, S. U., and Pedersen, A. O. (1990) Multiple fatty acid binding to albumin in human blood plasma Eur. J. Biochem. 189, 343-349 (Pubitemid 20146018)
15. Bahr, R., Hostmark, A. T., Newsholme, E. A., Gronnerod, O., and Sejersted, O. M. (1991) Effect of exercise on recovery changes in plasma levels of FFA, glycerol, glucose and catecholamines Acta Physiol. Scand. 143, 105-115
16. Kurien, V. A. and Oliver, M. F. (1971) Free fatty acids during acute myocardial infarction Prog. Cardiovasc. Dis. 13, 361-373
17. Paolisso, G., Tataranni, P. A., Foley, J. E., Bogardus, C., Howard, B. V., and Ravussin, E. (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM Diabetologia 38, 1213-1217
18. 13C NMR study J. Biol. Chem. 258, 9262-9269
19. Cistola, D. P., Small, D. M., and Hamilton, J. A. (1987) Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. I. The filling of individual fatty acid binding sites J. Biol. Chem. 262, 10971-10979
20. 13C NMR study Proc. Natl. Acad. Sci. U.S.A. 81, 3718-3722
21. Cistola, D. P., Small, D. M., and Hamilton, J. A. (1987) Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. II. Electrostatic interactions in individual fatty acid binding sites J. Biol. Chem. 262, 10980-10985
22. Hamilton, J. A. (1989) Medium-chain fatty acid binding to albumin and transfer to phospholipid bilayers Proc. Natl. Acad. Sci. U.S.A. 86, 2663-2667 (Pubitemid 19112606)
23. Hamilton, J. A., Era, S., Bhamidipati, S. P., and Reed, R. G. (1991) Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin Proc. Natl. Acad. Sci. U.S.A. 88, 2051-2054 (Pubitemid 21916351)
24. 13C NMR studies of the binding of medium-chain fatty acids to human serum albumin J. Lipid Res. 35, 458-467
25. Ho, J. K., Moser, H., Kishimoto, Y., and Hamilton, J. A. (1995) Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy J. Clin. Invest. 96, 1455-1463
26. Choi, J.-K., Ho, J., Curry, S., Qin, D., Bittman, R., and Hamilton, J. A. (2002) Interactions of very long-chain saturated fatty acids with serum albumin J. Lipid Res. 43, 1000-1010 (Pubitemid 34760870)
27. Simard, J. R., Zunszain, P. A., Ha, C.-E., Yang, J. S., Bhagavan, N. V., Petitpas, I., Curry, S., and Hamilton, J. A. (2005) Locating high-affinity fatty acid-binding sites on albumin by X-ray crystallography and NMR spectroscopy Proc. Natl. Acad. Sci. U.S.A. 102, 17958-17963 (Pubitemid 41798484)
28. Simard, J. R., Zunszain, P. A., Hamilton, J. A., and Curry, S. (2006) Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis J. Mol. Biol. 361, 336-351 (Pubitemid 44092787)
29. Bhattacharya, A. A., Grhune, T., and Curry, S. (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin J. Mol. Biol. 303, 721-732
30. Petitpas, I., Grhune, T., Bhattacharya, A. A., and Curry, S. (2001) Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids J. Mol. Biol. 314, 955-960 (Pubitemid 34073060)
31. Schleucher, J., Schwendinger, M., Sattler, M., Schmidt, P., Schedletzky, O., Glaser, S. J., Sørensen, O. W., and Griesinger, C. (1994) A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients J. Biomol. NMR 4, 301-306
32. Sarver, R. W., Gao, H., and Tian, F. (2005) Determining molecular binding sites on human serum albumin by displacement of oleic acid Anal. Biochem. 347, 297-302 (Pubitemid 41681817)
33. Gill, S. C. and von Hippel, P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data Anal. Biochem. 182, 319-326 (Pubitemid 19277112)
34. Cistola, D. P. (1985) Physicochemical Studies of Fatty Acids in Model Biological Systems (albumin, lipid bilayers, X-ray diffraction, non-esterified, nuclear magnetic resonance, NMR), ProQuest/UMI, Ann Arbor, MI.
35. 15N chemical shift referencing in biomolecular NMR J. Biomol. NMR 6, 135-140
36. Brunaldi, K., Huang, N., and Hamilton, J. A. (2010) Fatty acids are rapidly delivered to and extracted from membranes by methyl-β-cyclodextrin J. Lipid Res. 51, 120-131
37. Kilsdonk, E. P., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., and Rothblat, G. H. (1995) Cellular cholesterol efflux mediated by cyclodextrins J. Biol. Chem. 270, 17250-17256
38. Yancey, P. G., Rodrigueza, W. V., Kilsdonk, E. P., Stoudt, G. W., Johnson, W. J., Phillips, M. C., and Rothblat, G. H. (1996) Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux J. Biol. Chem. 271, 16026-16034 (Pubitemid 26236215)
39. Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., and Curry, S. (2001) Crystal structure analysis of warfarin binding to human serum albumin: Anatomy of drug site I J. Biol. Chem. 276, 22804-22809
40. Curry, S., Brick, P., and Franks, N. P. (1999) Fatty acid binding to human serum albumin: New insights from crystallographic studies Biochim. Biophys. Acta 1441, 131-140 (Pubitemid 29537733)
41. Bocedi, A., Notari, S., Menegatti, E., Fanali, G., Fasano, M., and Ascenzi, P. (2005) Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin FEBS J. 272, 6287-6296 (Pubitemid 41815617)
42. Ascenzi, P., Bocedi, A., Notari, S., Menegatti, E., and Fasano, M. (2005) Heme impairs allosterically drug binding to human serum albumin Sudlow's site I Biochem. Biophys. Res. Commun. 334, 481-486 (Pubitemid 40982392)
43. Brünger, A. T. (1997) X-ray crystallography and NMR reveal complementary views of structure and dynamics Nat. Struct. Biol. 4 (Suppl.) 862-865
44. Isaksson, J., Nyström, S., Derbyshire, D., Wallberg, H., Agback, T., Kovacs, H., Bertini, I., Giachetti, A., and Luchinat, C. (2009) Does a fast nuclear magnetic resonance spectroscopy-and X-ray crystallography hybrid approach provide reliable structural information of ligand-protein complexes? A case study of metalloproteinases J. Med. Chem. 52, 1712-1722
45. Irie, T. and Uekama, K. (1997) Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation J. Pharm. Sci. 86, 147-162 (Pubitemid 27078377)
46. Brewster, M. E. and Loftsson, T. (2007) Cyclodextrins as pharmaceutical solubilizers Adv. Drug Delivery Rev. 59, 645-666 (Pubitemid 47299263)
47. Cox, P. J., Ryan, D. A., Hollis, F. J., Harris, A. M., Miller, A. K., Vousden, M., and Cowley, H. (2000) Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans Drug Metab. Dispos. 28, 772-780 (Pubitemid 30470827)
48. Goodman, L. S., Limbird, L. E., Milinoff, P. B., Ruddon, R. W., and Goodman Gilman, A., Eds. (1996) Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York.